Jianya Zhou, Pei Zhang, Jing Zheng, Yuping Li, Xiaolong Ma, Weina Huang. "Lorlatinib as first-line therapy for ALK-positive advanced non-small cell lung cancer: A retrospective, multicenter, real-world study from China.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20740